Phase III trial of Minocycline topical Gel (HY01) in patients with Papulopustular Rosacea
Latest Information Update: 24 Sep 2019
At a glance
- Drugs Minocycline (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Acronyms MARS-3
Most Recent Events
- 24 Sep 2019 New trial record
- 20 Sep 2019 According to a Hovione media release, the company anticipates initiating this trial subject to entering into a strategic collaboration with a commercial partner by fourth quarter of 2 aiming at filing the NDA during 2021.
- 20 Sep 2019 According to a Hovione media release, the company received guidance for the design and clinical endpoints for HY01 at a recent End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA).